サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1684335

医療用処方的分析の世界市場：コンポーネント別・展開方式別・用途別・最終用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

Healthcare Prescriptive Analytics Market, By Component, By Deployment, By Application, By End-use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 322 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
医療用処方的分析の世界市場：コンポーネント別・展開方式別・用途別・最終用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2025年02月04日
発行: AnalystView Market Insights
ページ情報: 英文 322 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

医療用処方的分析の市場規模は2024年に149億4,053万米ドルとなり、2025年から2032年にかけてCAGR 25.40%で拡大

医療用処方的分析の市場力学

医療用処方的分析市場の成長は、膨大な量のデータを生成する電子カルテ（EHR）とウェアラブルヘルス技術の採用が加速していることが背景にあります。さらに、糖尿病や心血管疾患などの慢性疾患の流行が加速しているため、正確で個別化された治療推奨が必要とされています。さらに、コスト効率に優れた医療の提供に対する需要が高まっていることから、医療提供者はアナリティクスを活用して運営コストを削減し、患者の転帰を改善しようとしています。医療用処方的分析は、特に患者ケアと業務効率の改善において、大きな成長機会をもたらします。処方モデルには、個別化医療を改善する可能性があります。処方的分析により、臨床医は健康データを用いて患者に特化した治療を提供することができます。処方的分析にAIと機械学習を応用することで、患者が必要とする可能性のあるものを予測し、資源配分を最適化し、病院の処理能力を向上させる予測モデルも可能になります。しかし、データのプライバシーとセキュリティに関する懸念、患者データを取り巻く厳しい規制の枠組み、処方的分析ソリューションの導入にかかる高コストが、普及の妨げになる可能性があります。

医療用処方的分析市場：主な考察

医療組織のデータに基づく意思決定プロセスのための高度なツールと分析プラットフォームに対する需要が増加しているため、ソフトウェア分野が市場を独占しています。

病院の財務パフォーマンスを最適化し、コストを削減し、請求精度を向上させる必要性が高まっていることから、財務管理分野が最も速いペースで成長すると予測されています。処方的分析は、医療組織がリソースを効果的に管理し、財務の非効率性を最小限に抑えるのに役立ちます。

クラウドベースの展開モデルは、市場で最も急成長しているセグメントです。クラウドソリューションは拡張性、柔軟性、コスト効率が高いため、医療組織は大量のデータを処理し、リアルタイムの洞察を提供するためにこのようなソリューションを必要としています。

北米が市場をリードしているのは、先進的な医療技術の採用率が高く、医療インフラが健全で、政府の取り組みが積極的だからです。医療情報技術への投資が活発で、データ主導型の医療サービスに対する需要が高いことも、この地域の利点となっています。

医療用処方的分析市場：セグメンテーション分析

世界の医療用処方的分析市場は、コンポーネント、デプロイメント、用途、最終用途、地域に基づいてセグメント化されます。

用途別では、臨床管理、財務管理、運営管理、その他に分けられます。臨床管理は、治療と患者ケアの改善という重要な性質のため、市場で最大のシェアを占めています。増加する処方的分析の使用事例の1つには、患者の治療計画の個別化、病気の進行予測、医療提供の改善などがあります。治療戦略の最適化、患者監視の改善モニタリング、病院からの再入院の最小化などは、処方的分析によって実現されます。財務管理は市場で最も急成長している分野です。急速な成長は、医療組織が財務運営を最適化する必要性に後押しされています。このような成長には、コスト削減と収益サイクル管理の改善に対する医療機関の需要の高まりも含まれています。財務管理の処方的分析は、組織が経費を予測し、請求の精度を向上させ、リソースを無駄に使用している箇所を検出する力を与えます。

最終用途別では、市場は病院、クリニック、その他に分けられます。病院が市場を独占している主な理由は、病院が患者のケアと治療の中核をなす場所だからです。処方的分析は、臨床ワークフロー、リソース配分、患者の転帰を最適化します。処方的分析を統合することで、病院は患者数の予測を改善し、診断精度を向上させ、パーソナライズされた治療計画を決定することができます。市場セグメンテーションでは、診療所が最も速いペースで成長しています。小規模な医療施設では、より良い治療を提供するために費用対効果の高いソリューションが必要とされるため、患者管理を強化し、治療プロトコルを最適化するために処方的分析を採用するクリニックが増えています。処方的分析は、予約スケジューリングの合理化、患者のニーズの予測、患者の流れの管理といった点で診療所に役立ちます。患者数の増加は特に外来診療に関連しており、アナリティクス主導型ソリューションの必要性が急速に高まっています。

医療用処方的分析市場：地域別分析

北米が最大の市場シェアを占めているのは、高度な医療テクノロジーの高い導入率、広範な医療インフラ、政府の強力な支援によるものです。米国が市場の大半を占めており、医療ITソリューションと処方的分析に莫大な投資を行っています。北米は、AIとデータアナリティクスのイノベーションの開発と医療の最適化に対する大きな需要により、今後も成長が見込まれます。アジア太平洋地域は、予測期間中に最も急成長するセグメントです。中国やインドなどの国々の急速な医療インフラの拡大と人口増加による健康需要の増加が、アナリティクスソリューションの適応を急速に進めています。この地域の成長の原動力は、デジタルヘルス技術への支出の増加と、医療の提供および管理改善への注力の強化です。

医療用処方的分析市場：競合情勢

世界の医療用処方的分析市場は競争が激しく、数多くの大手企業がイノベーションとテクノロジーを推進しています。IBM CorporationとOracle Corporationが市場を牽引する主要企業です。市場の主要企業はIBM CorporationとOracle Corporationの2社で、臨床、業務、財務管理に総合的なソリューションを提供する包括的なアナリティクス・プラットフォームにより、大きな市場シェアを占めています。医療システム向けに高度な最適化ソリューションを提供する企業が競合を激化させています。市場の特徴としては、戦略的パートナーシップ、買収、製品革新があり、医療分析ソリューションに対する世界の需要の高まりに対応しています。競合情勢は、より大きな市場シェアを獲得するために各社が提供する製品を改善する一連の取り組みを通じて進化し続けています。

目次

第1章 医療用処方的分析市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 医療用処方的分析の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 医療用処方的分析市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 医療用処方的分析市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 医療用処方的分析の市場情勢

  • 医療用処方的分析の市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 医療用処方的分析市場：コンポーネント別

  • 概要
    • セグメント別シェア分析：コンポーネント別
    • ソフトウェア
    • サービス

第8章 医療用処方的分析市場：展開方式別

  • 概要
    • セグメント別シェア分析：展開方式別
    • オンプレミス
    • クラウドベース

第9章 医療用処方的分析市場：用途別

  • 概要
    • セグメント別シェア分析：用途別
    • 臨床管理
    • 財務管理
    • 運用管理
    • その他

第10章 医療用処方的分析市場：最終用途別

  • 概要
    • セグメント別シェア分析：最終用途別
    • 病院
    • クリニック
    • その他

第11章 医療用処方的分析市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ（LATAM）
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ（MEA）
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析：医療用処方的分析業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • AIMMS
    • Alteryx
    • Deerwalk Inc.
    • FICO
    • Frontline Systems, Inc.
    • Gurobi Optimization, LLC
    • Health Catalyst
    • IBM Corporation
    • Optum, Inc.
    • Oracle Corporation

第13章 AnalystViewの全方位的分析

目次
Product Code: ANV4733

REPORT HIGHLIGHT

Healthcare Prescriptive Analytics Market size was valued at US$ 14,940.53 Million in 2024, expanding at a CAGR of 25.40% from 2025 to 2032.

Healthcare prescriptive analytics is a technique that uses advanced data analysis techniques, such as artificial intelligence, machine learning, and optimization algorithms, to recommend actionable solutions for improving healthcare outcomes. It is the branch of analytics that goes beyond descriptive and diagnostic analysis, focusing on understanding past data and identifying the root causes of healthcare issues. Prescriptive analytics will provide a healthcare organization with data-driven recommendations for the best response to challenges regarding patient care, resource distribution, or operations. It can predict future trends, suggest customized treatment plans, optimize the workflow of a hospital, and improve decision-making based on extensive data from sources like EHRs, clinical trial results, patient demographics, and even devices for real-time monitoring.

Healthcare Prescriptive Analytics Market- Market Dynamics

The growth of the healthcare prescriptive analytics market is driven by the escalating adoption of Electronic Health Records (EHRs) and wearable health technologies, which generate vast amounts of data. Additionally, the propelling prevalence of chronic diseases, such as diabetes and cardiovascular conditions, necessitates precise, personalized treatment recommendations. Moreover, the growing demand for cost-efficient healthcare delivery propels healthcare providers to leverage analytics to reduce operational costs and improve patient outcomes. Healthcare prescriptive analytics presents significant opportunities for growth, particularly in improving patient care & operational efficiency. There is potential scope in prescriptive models to improve personalized medicine. With prescriptive analytics, clinicians can provide patient-specific treatments with their health data. The application of AI & machine learning in prescriptive analytics also makes possible predictive models that can predict what patients may need, optimize resource allocation, and enhance hospital throughput. However, data privacy and security concerns, strict regulatory framework surrounding patient data, and the high cost of implementing prescriptive analytics solutions, may hinder widespread adoption.

Healthcare Prescriptive Analytics Market- Key Insights

The software segment dominates the market as the demand for an advanced tool and analytical platform for healthcare organizations' data-based decision-making processes is increasing.

The financial management segment is projected to grow at the fastest pace owing to the escalating need to optimize hospital financial performance, reduce costs, and improve billing accuracy. Prescriptive analytics helps healthcare organizations effectively manage resources and minimize financial inefficiencies.

The cloud-based deployment model is the fastest-growing segment in the market. Cloud solutions are scalable, flexible, and cost-efficient; therefore, healthcare organizations need such solutions to handle large volumes of data and provide real-time insights.

North America leads in the market because of its high adoption rates of advanced healthcare technologies, healthy healthcare infrastructures, and auspicious government initiatives. Strong investments in healthcare information technologies and high demand for data-driven healthcare services also benefit the region.

Healthcare Prescriptive Analytics Market- Segmentation Analysis:

The Global Healthcare Prescriptive Analytics Market is segmented on the basis of Component, Deployment, Application, End-use, and Region.

By application, the market is divided into clinical management, financial management, operation management, others. Clinical management held the largest share in the market due to the critical nature of the improvement in treatment and patient care. One of the increasing prescriptive analytics use cases includes personalizing patient treatment plans, predicting disease progression, and improving health care delivery. Optimizing treatment strategies, monitoring improvement in patient surveillance, and minimizing readmissions from hospitals are achieved with prescriptive analytics. Financial management is the fastest-growing segment in the market. Rapid growth is being encouraged by the need for healthcare organizations to optimize financial operations. Such growth also includes an increased demand by health organizations to cut costs and improve revenue cycle management. Prescriptive analytics of financial management empowers an organization to forecast expenses, improve accuracy in billing, and detect where one is wastefully using resources.

By end-use, the market is divided into hospitals, clinics, and others. The hospital segment dominates the market primarily because hospitals are the places at the core of patient care and treatment. Prescriptive analytics optimizes clinical workflows, resource distribution, and patient outcomes. Prescriptive analytics integration allows hospitals to better predict patient volumes, improve diagnosis accuracy, and decide on personalized treatment plans. The clinics segment is growing at the fastest rate in the market. Clinics increasingly adopt prescriptive analytics to enhance patient management and optimize treatment protocols because smaller healthcare facilities require cost-effective solutions for better care delivery. Prescriptive analytics can be helpful to clinics in terms of streamlined appointment scheduling, predicting patients' needs, and managing patient flow. The growth in patient volume is especially related to outpatient services, and the need for analytics-driven solutions has intensified rapidly.

Healthcare Prescriptive Analytics Market- Geographical Insights

North America held the largest market share due to the high adoption of advanced healthcare technologies, extensive healthcare infrastructure, and strong government support. The US has most of the market, with vast investments in health IT solutions and prescriptive analytics. North America is expected to continue growing with the development of AI and data analytics innovations and the significant demand for healthcare optimization. The Asia-Pacific region is the fastest-growing segment during the forecast period. The rapid healthcare infrastructure expansion of countries like China & India and increasing health demands due to population growth have fast-forwarded the adaptation of analytics solutions. The growth in the region is driven by increased spending on digital health technologies and a stronger focus on healthcare delivery and management improvement.

Healthcare Prescriptive Analytics Market- Competitive Landscape:

The global healthcare prescriptive analytics market is competitive, with numerous leading players pushing innovation and technology. IBM Corporation and Oracle Corporation are the main companies driving the market forward. The two major companies in the market are IBM Corporation and Oracle Corporation, which hold significant market shares because of a comprehensive analytics platform that provides holistic solutions to clinical, operational, and financial management. Companies providing advanced optimization solutions for healthcare systems intensify the competition. The market characterization has strategic partnerships, acquisitions, and product innovation, catering to the growing global demand for healthcare analytics solutions. The competitive landscape continues to evolve through a series of efforts by firms to improve their offerings toward capturing larger market shares.

Recent Developments:

October 2023: Health Catalyst launched the Touchstone prescriptive analytics solution to help healthcare organizations optimize clinical and operational decision-making. The new solution uses machine learning and predictive modeling to apply insights to improve patient outcomes and reduce costs.

August 2023: IBM Corporation announced a strategic collaboration with Optum, Inc. for collaboration integrating IBM's prescriptive analytics tools into Optum's healthcare data platforms to support predictive modeling for population health management and personalized medicine.

June 2023: Oracle Corporation expanded its healthcare analytics offerings with the launch of Oracle Health Prescriptive Analytics, a cloud-based solution that enables healthcare providers to streamline resource allocation and improve patient care delivery. The solution integrates seamlessly with Oracle's existing EHR systems.

March 2023: FICO collaborated with Deerwalk Inc. on integrating FICO's prescriptive analytics expertise with Deerwalk's solutions related to healthcare data management. The collaboration will deliver advanced risk stratification and care coordination analytics through value-based care models.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEALTHCARE PRESCRIPTIVE ANALYTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • AIMMS
  • Alteryx
  • Deerwalk Inc.
  • FICO
  • Frontline Systems, Inc.
  • Gurobi Optimization, LLC
  • Health Catalyst
  • IBM Corporation
  • Optum, Inc.
  • Oracle Corporation

GLOBAL HEALTHCARE PRESCRIPTIVE ANALYTICS MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Software
  • Service

GLOBAL HEALTHCARE PRESCRIPTIVE ANALYTICS MARKET, BY DEPLOYMENT- MARKET ANALYSIS, 2019 - 2032

  • On-premise
  • Cloud-based

GLOBAL HEALTHCARE PRESCRIPTIVE ANALYTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Clinical management
  • Financial management
  • Operation management
  • Others

GLOBAL HEALTHCARE PRESCRIPTIVE ANALYTICS MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Other

GLOBAL HEALTHCARE PRESCRIPTIVE ANALYTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Healthcare Prescriptive Analytics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Healthcare Prescriptive Analytics Market Snippet By Component
    • 2.1.2. Healthcare Prescriptive Analytics Market Snippet By Deployment
    • 2.1.3. Healthcare Prescriptive Analytics Market Snippet By Application
    • 2.1.4. Healthcare Prescriptive Analytics Market Snippet By End Use
    • 2.1.5. Healthcare Prescriptive Analytics Market Snippet by Country
    • 2.1.6. Healthcare Prescriptive Analytics Market Snippet by Region
  • 2.2. Competitive Insights

3. Healthcare Prescriptive Analytics Key Market Trends

  • 3.1. Healthcare Prescriptive Analytics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Healthcare Prescriptive Analytics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Healthcare Prescriptive Analytics Market Opportunities
  • 3.4. Healthcare Prescriptive Analytics Market Future Trends

4. Healthcare Prescriptive Analytics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Healthcare Prescriptive Analytics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Healthcare Prescriptive Analytics Market Landscape

  • 6.1. Healthcare Prescriptive Analytics Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Healthcare Prescriptive Analytics Market - By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
    • 7.1.2. Software
    • 7.1.3. Service

8. Healthcare Prescriptive Analytics Market - By Deployment

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Deployment, 2024 & 2032 (%)
    • 8.1.2. On-premise
    • 8.1.3. Cloud-based

9. Healthcare Prescriptive Analytics Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Clinical management
    • 9.1.3. Financial management
    • 9.1.4. Operation management
    • 9.1.5. Others

10. Healthcare Prescriptive Analytics Market - By End Use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Clinics
    • 10.1.4. Others

11. Healthcare Prescriptive Analytics Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Healthcare Prescriptive Analytics Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Healthcare Prescriptive Analytics Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Healthcare Prescriptive Analytics Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Healthcare Prescriptive Analytics Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Healthcare Prescriptive Analytics Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Healthcare Prescriptive Analytics Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. AIMMS
    • 12.2.2. Alteryx
    • 12.2.3. Deerwalk Inc.
    • 12.2.4. FICO
    • 12.2.5. Frontline Systems, Inc.
    • 12.2.6. Gurobi Optimization, LLC
    • 12.2.7. Health Catalyst
    • 12.2.8. IBM Corporation
    • 12.2.9. Optum, Inc.
    • 12.2.10. Oracle Corporation

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us